Devices and methods for treatment of heart failure and associated conditions
Devices and methods of use identification, treatment, and/or management of heart failure and/or associated conditions. Methods may include providing a baroreflex therapy system, providing an implantable measurement device proximate a blood vessel of a patient, the implantable measurement device including a plurality of electrodes, determining an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle, generating at least one signal representative of a pressure waveform based on the impedance, activating, deactivating or otherwise modulating the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.
1. A method of treating heart failure, comprising:
causing a baroreflex therapy system to be manufactured and made available to a user, the baroreflex therapy system configured to be implanted within a patient;
causing an implantable measurement device to be manufactured and made available to the user, the implantable measurement device configured to be implantable proximate a blood vessel of the patient, the implantable measurement device including a plurality of electrodes; and
causing a control system to be manufactured and made available to the user, the control system configured to be coupled to the baroreflex therapy system and the implantable measurement device, the control system programmed to automatically:
determine an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle;
generate at least one signal representative of a pressure waveform based on the impedance;
activate, deactivate or otherwise modulate the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.
2. The method of claim 1 , wherein the control system is further programmed to automatically:
determine an augmentation index from the at least one signal representative of a pressure waveform;
activate, deactivate or otherwise modulate the baroreflex therapy system based on the augmentation index.
3. The method of claim 1 , wherein the control system is further programmed to automatically:
determine arterial compliance from the at least one signal representative of a pressure waveform;
activate, deactivate or otherwise modulate the baroreflex therapy system based on the arterial compliance.
4. The method of claim 1 , wherein the control system is further programmed to automatically:
determine a myocardial oxygen consumption from the at least one signal representative of a pressure waveform;
activate, deactivate or otherwise modulate the baroreflex therapy system based on the myocardial oxygen consumption.
5. The method of claim 1 , wherein the control system is further programmed to automatically:
determine an augmentation index from the at least one signal representative of a pressure waveform;
activate, deactivate or otherwise modulate the baroreflex therapy system based on the augmentation index.
6. The method of claim 1 , wherein the control system is further programmed to automatically:
determine a parameter indicative of left ventricle mass from the at least one signal representative of a pressure waveform;
activate, deactivate or otherwise modulate the baroreflex therapy system based on the parameter indicative of left ventricle mass.
7. A method, comprising:
causing a baroreflex therapy system to be manufactured and made available to a user, the baroreflex therapy system configured to be implantable within a patient;
causing an implantable measurement device to be manufactured and made available to the user, the implantable measurement device configured to be implantable proximate a blood vessel of the patient, the implantable measurement device including a plurality of electrodes;
causing a control system to be manufactured and made available to the user, the control system configured to be coupled to the baroreflex therapy system and the implantable measurement device; and
programming the control system with instruction recorded on a tangible medium for operating the control system to deliver a therapy to treat heart failure, the instructions comprising:
determine an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle;
generate at least one signal representative of a pressure waveform based on the impedance;
activate, deactivate or otherwise modulate the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.
8. A system, comprising:
an implantable baroreflex activation device;
an implantable measurement device configured to be implanted proximate a blood vessel of a patient, the implantable measurement device including a plurality of electrodes; and
a control system coupled to the baroreflex activation device and the implantable measurement device, the control system programmed to automatically:
determine an impedance of the blood vessel with the implantable measurement device over a time period of at least one cardiac cycle;
generate at least one signal representative of a pressure waveform based on the impedance;
activate, deactivate or otherwise modulate the baroreflex therapy system to deliver a therapy to treat heart failure based at least in part on the at least one signal representative of the pressure waveform.
9. The system of claim 8 , wherein the implantable measurement device is integrated with the implantable baroreflex activation device.